Physician profile
Daniel Seward
NPI 1689652620
$1,706.94
in general payments reported to CMS, 2019-2025
19 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $349 · 2021: $90.29 · 2022: $51.55 · 2023: $396 · 2024: $150 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $871.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $548.94 | 2019-2025 | Farxiga, Breztri |
| Indivior INC. | $184.68 | 2019-2025 | Sublocade |
| Idorsia Pharmaceuticals US INC | $145.66 | 2023 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.58 | 2019-2023 | Jardiance |
| Pfizer INC. | $103.35 | 2023-2025 | |
| Abbvie INC. | $99.83 | 2021-2025 | Qulipta |
| Sanofi-Aventis U.S. LLC | $74.51 | 2020-2023 | |
| Exact Sciences Corporation | $69.92 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $47.83 | 2023-2025 | Trelegy Ellipta, Shingrix |
| Amgen INC. | $37.94 | 2025 | Repatha |
| Novo Nordisk INC | $37.59 | 2025 | Wegovy |
| Baxter Healthcare | $36.89 | 2025 | Hillrom - Retinavue 700 Imager, Hillrom - Carnation Ambulatory Monitor |
| Genentech USA, INC. | $35.65 | 2019-2020 | |
| Lilly USA, LLC | $34.95 | 2021-2025 | Mounjaro |
| Masimo Corporation | $34.58 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $28.17 | 2023 | Rexulti, Abilify Maintena |
| Medicomp INC | $18.78 | 2023 | Telepatch Cardiac Monitor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.90 | 2025 | Xifaxan |
| Braeburn INC. | $16.19 | 2023 | Brixadi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Seward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.